Rising Demand and Innovations Drive Growth in the Chronic Pain Treatment Market

Mordor Intelligence has published a new report on the Chronic Pain Treatment Market, offering a comprehensive analysis of trends, growth drivers, and future projections.   

The chronic pain treatment market is experiencing significant growth, propelled by the increasing prevalence of chronic pain conditions, technological advancements in treatment modalities, and a growing geriatric population. Chronic pain, defined as pain persisting for more than 12 weeks, affects a substantial portion of the global population, leading to diminished quality of life and increased healthcare expenditures. According to a report by Mordor Intelligence, the global chronic pain treatment market size was estimated at USD 26.95 billion in 2025 and is projected to reach USD 39.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.88% during the forecast period. ​

Key Trends

1. Increasing Prevalence of Chronic Pain

   The incidence of chronic pain is on the rise globally, affecting approximately 20% of adults. In the United States, a report by the Centers for Disease Control and Prevention (CDC) indicated that in 2023, 24.3% of adults experienced chronic pain, with 8.5% reporting high-impact chronic pain that significantly limited daily activities. This growing prevalence underscores the urgent need for effective pain management solutions.

2. Technological Advancements in Treatment

   Innovations in both pharmacological and device-based therapies are enhancing the efficacy and safety of chronic pain treatments. For instance, in February 2023, Anglo-French Drugs & Industries Ltd. introduced AFD-NP, a combination of Nortriptyline and Pregabalin, designed to manage moderate to severe neuropathic pain. Such advancements are expanding the therapeutic arsenal available to clinicians and patients alike.

3. Aging Population

   The global demographic shift towards an aging population is contributing to the increased demand for chronic pain treatments. The World Health Organization projects that by 2030, one in six individuals worldwide will be aged 60 years or older, with the population in this age group expected to grow from 1 billion in 2020 to 1.4 billion. Older adults are more susceptible to chronic conditions associated with pain, thereby driving market growth.

Market Segmentation

The chronic pain treatment market can be segmented based on product type, application, end-user, and geography.

1. By Product Type

   • Drugs

     • Analgesics: Medications that relieve pain without causing loss of consciousness.

     • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Drugs that reduce inflammation and alleviate pain.

     • Anticonvulsants: Medications primarily used to treat seizures but also effective in neuropathic pain.

     • Antidepressants: Drugs that can modulate pain perception and are used in chronic pain management.

   • Devices

     • Neurostimulation Devices: Implanted or external devices that deliver electrical stimulation to nerves to alleviate pain.

     • Analgesic Infusion Pumps: Devices that deliver controlled amounts of pain medication directly to the site of pain.

2. By Application

   • Neuropathic Pain: Pain resulting from damage to the nervous system, often described as burning or shooting sensations.​

   • Arthritic Pain: Pain associated with arthritis, characterized by joint inflammation and stiffness.​

   • Post-Surgical Pain: Pain experienced after surgical procedures, requiring effective management to facilitate recovery.​

   • Cancer Pain: Pain related to cancer itself or as a side effect of cancer treatments.​

   • Others: Includes pain conditions such as fibromyalgia, chronic back pain, and migraines.​

3. By End-User

   • Hospitals: Primary centers for acute pain management and complex pain procedures.​

   • Clinics: Outpatient settings providing ongoing pain management services.​

   • Other End-Users: Includes home healthcare settings and rehabilitation centers.

Get a Customized Report Tailored to Your Requirements. – ​

Key Players

The chronic pain treatment market is characterized by the presence of several key players who are instrumental in driving innovation and addressing the evolving needs of patients. Notable companies include:

• Pfizer Inc.: A global pharmaceutical corporation offering a range of pain management medications.​

• Medtronic PLC: A medical device company known for its neurostimulation devices used in pain management.​

• Abbott Laboratories: Provides both pharmaceutical and device-based pain management solutions.​

• Novartis AG: Offers a portfolio of medications addressing various chronic pain conditions.​

• Becton, Dickinson, and Company: Specializes in medical technology, including devices used in pain management.​

Conclusion

The chronic pain treatment market is poised for substantial growth, driven by the increasing prevalence of chronic pain conditions, technological advancements in treatment options, and a growing aging population. As awareness of chronic pain and its impact on quality of life continues to rise, the demand for effective and innovative pain management solutions is expected to escalate. Key industry players are actively engaged in research and development to introduce new therapies and devices, aiming to meet the diverse needs of patients and healthcare providers.

Industry Related Reports